APO Research
Talk to an analyst

APO RESEARCH · REPORT

Muscarinic Acetylcholine Receptor M4

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Muscarinic Acetylcholine Receptor M4 Market Outlook and Growth Opportunities 2026

19 December 2025190 pages

Choose your research edition.

Industry ResearchMuscarinic Acetylcholine Receptor M4 Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Muscarinic Acetylcholine Receptor M4 Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Muscarinic Acetylcholine Receptor M4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Muscarinic Acetylcholine Receptor M4 Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Muscarinic Acetylcholine Receptor M4 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Muscarinic Acetylcholine Receptor M4 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Muscarinic Acetylcholine Receptor M4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Muscarinic Acetylcholine Receptor M4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Muscarinic Acetylcholine Receptor M4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Muscarinic Acetylcholine Receptor M4 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Muscarinic Acetylcholine Receptor M4 market include Sumitomo Dainippon Pharma Co Ltd, AstraZeneca Plc, NeuroHealing Pharmaceuticals Inc, Karuna Pharmaceuticals Inc, Heptares Therapeutics Ltd and Anavex Life Sciences Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Muscarinic Acetylcholine Receptor M4 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Muscarinic Acetylcholine Receptor M4 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Muscarinic Acetylcholine Receptor M4 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Muscarinic Acetylcholine Receptor M4 market size, projected growth trends, production technologies, key applications, and end-use industries.

Muscarinic Acetylcholine Receptor M4 Segment by Company

Sumitomo Dainippon Pharma Co Ltd

AstraZeneca Plc

NeuroHealing Pharmaceuticals Inc

Karuna Pharmaceuticals Inc

Heptares Therapeutics Ltd

Anavex Life Sciences Corp

Muscarinic Acetylcholine Receptor M4 Segment by Type

Tropicamide

VU-0467154

ANAVEX-273

Others

Muscarinic Acetylcholine Receptor M4 Segment by Application

Amnesia

Cognitive Disorders

Psychosis

Others

Muscarinic Acetylcholine Receptor M4 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Muscarinic Acetylcholine Receptor M4 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Muscarinic Acetylcholine Receptor M4 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Muscarinic Acetylcholine Receptor M4 significant trends, drivers, influence factors in global and regions.

6. To analyze Muscarinic Acetylcholine Receptor M4 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Muscarinic Acetylcholine Receptor M4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Muscarinic Acetylcholine Receptor M4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Muscarinic Acetylcholine Receptor M4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Muscarinic Acetylcholine Receptor M4 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Muscarinic Acetylcholine Receptor M4 industry.

Chapter 3: Detailed analysis of Muscarinic Acetylcholine Receptor M4 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Muscarinic Acetylcholine Receptor M4 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Muscarinic Acetylcholine Receptor M4 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Muscarinic Acetylcholine Receptor M4 Industry Trends Table 2. Muscarinic Acetylcholine Receptor M4 Industry Drivers Table 3. Muscarinic Acetylcholine Receptor M4 Industry Opportunities and Challenges Table 4. Muscarinic Acetylcholine Receptor M4 Industry Restraints Table 5. Global Muscarinic Acetylcholine Receptor M4 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Muscarinic Acetylcholine Receptor M4 Revenue Share by Company (2021-2026) Table 7. Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Muscarinic Acetylcholine Receptor M4 Sales Volume Share by Company (2021-2026) Table 9. Global Muscarinic Acetylcholine Receptor M4 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Muscarinic Acetylcholine Receptor M4 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Muscarinic Acetylcholine Receptor M4 Key Company Manufacturing Base & Headquarters Table 12. Global Muscarinic Acetylcholine Receptor M4 Company, Product Type & Application Table 13. Global Muscarinic Acetylcholine Receptor M4 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Muscarinic Acetylcholine Receptor M4 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tropicamide Table 18. Significant Companies of VU-0467154 Table 19. Significant Companies of ANAVEX-273 Table 20. Significant Companies of Others Table 21. Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Type (2021-2026) & (W Units) Table 23. Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Type (2027-2032) & (W Units) Table 24. Global Muscarinic Acetylcholine Receptor M4 Sales Volume Share by Type (2021-2026) Table 25. Global Muscarinic Acetylcholine Receptor M4 Sales Volume Share by Type (2027-2032) Table 26. Global Muscarinic Acetylcholine Receptor M4 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Muscarinic Acetylcholine Receptor M4 Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Muscarinic Acetylcholine Receptor M4 Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type (2021-2026) Table 30. Global Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Amnesia Table 32. Significant Companies of Cognitive Disorders Table 33. Significant Companies of Psychosis Table 34. Significant Companies of Others Table 35. Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Application (2021-2026) & (W Units) Table 37. Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Application (2027-2032) & (W Units) Table 38. Global Muscarinic Acetylcholine Receptor M4 Sales Volume Share by Application (2021-2026) Table 39. Global Muscarinic Acetylcholine Receptor M4 Sales Volume Share by Application (2027-2032) Table 40. Global Muscarinic Acetylcholine Receptor M4 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Muscarinic Acetylcholine Receptor M4 Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Muscarinic Acetylcholine Receptor M4 Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application (2021-2026) Table 44. Global Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application (2027-2032) Table 45. Global Muscarinic Acetylcholine Receptor M4 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 46. Global Muscarinic Acetylcholine Receptor M4 Sales by Region (2021-2026) & (W Units) Table 47. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Region (2021-2026) Table 48. Global Muscarinic Acetylcholine Receptor M4 Sales by Region (2027-2032) & (W Units) Table 49. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Region (2027-2032) Table 50. Global Muscarinic Acetylcholine Receptor M4 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Muscarinic Acetylcholine Receptor M4 Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Muscarinic Acetylcholine Receptor M4 Sales Value Share by Region (2021-2026) Table 53. Global Muscarinic Acetylcholine Receptor M4 Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Muscarinic Acetylcholine Receptor M4 Sales Value Share by Region (2027-2032) Table 55. Global Muscarinic Acetylcholine Receptor M4 Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Muscarinic Acetylcholine Receptor M4 Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Muscarinic Acetylcholine Receptor M4 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Global Muscarinic Acetylcholine Receptor M4 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Muscarinic Acetylcholine Receptor M4 Sales by Country (2021-2026) & (W Units) Table 60. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Country (2021-2026) Table 61. Global Muscarinic Acetylcholine Receptor M4 Sales by Country (2027-2032) & (W Units) Table 62. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Country (2027-2032) Table 63. Global Muscarinic Acetylcholine Receptor M4 Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Muscarinic Acetylcholine Receptor M4 Sales Value Market Share by Country (2021-2026) Table 65. Global Muscarinic Acetylcholine Receptor M4 Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Muscarinic Acetylcholine Receptor M4 Sales Value Market Share by Country (2027-2032) Table 67. Sumitomo Dainippon Pharma Co Ltd Company Information Table 68. Sumitomo Dainippon Pharma Co Ltd Business Overview Table 69. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Product Portfolio Table 71. Sumitomo Dainippon Pharma Co Ltd Recent Development Table 72. AstraZeneca Plc Company Information Table 73. AstraZeneca Plc Business Overview Table 74. AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Product Portfolio Table 76. AstraZeneca Plc Recent Development Table 77. NeuroHealing Pharmaceuticals Inc Company Information Table 78. NeuroHealing Pharmaceuticals Inc Business Overview Table 79. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Portfolio Table 81. NeuroHealing Pharmaceuticals Inc Recent Development Table 82. Karuna Pharmaceuticals Inc Company Information Table 83. Karuna Pharmaceuticals Inc Business Overview Table 84. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Portfolio Table 86. Karuna Pharmaceuticals Inc Recent Development Table 87. Heptares Therapeutics Ltd Company Information Table 88. Heptares Therapeutics Ltd Business Overview Table 89. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Product Portfolio Table 91. Heptares Therapeutics Ltd Recent Development Table 92. Anavex Life Sciences Corp Company Information Table 93. Anavex Life Sciences Corp Business Overview Table 94. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Product Portfolio Table 96. Anavex Life Sciences Corp Recent Development Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Muscarinic Acetylcholine Receptor M4 Distributors List Table 100. Muscarinic Acetylcholine Receptor M4 Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Muscarinic Acetylcholine Receptor M4 Product Image Figure 2. Global Muscarinic Acetylcholine Receptor M4 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Muscarinic Acetylcholine Receptor M4 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Muscarinic Acetylcholine Receptor M4 Sales (2021-2032) & (W Units) Figure 5. Global Muscarinic Acetylcholine Receptor M4 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Muscarinic Acetylcholine Receptor M4 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tropicamide Image Figure 10. VU-0467154 Image Figure 11. ANAVEX-273 Image Figure 12. Others Image Figure 13. Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Muscarinic Acetylcholine Receptor M4 Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Muscarinic Acetylcholine Receptor M4 Sales Volume Share by Type (2021-2032) Figure 16. Global Muscarinic Acetylcholine Receptor M4 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Muscarinic Acetylcholine Receptor M4 Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type (2021-2032) Figure 19. Amnesia Image Figure 20. Cognitive Disorders Image Figure 21. Psychosis Image Figure 22. Others Image Figure 23. Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Muscarinic Acetylcholine Receptor M4 Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Muscarinic Acetylcholine Receptor M4 Sales Volume Share by Application (2021-2032) Figure 26. Global Muscarinic Acetylcholine Receptor M4 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Muscarinic Acetylcholine Receptor M4 Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application (2021-2032) Figure 29. Global Muscarinic Acetylcholine Receptor M4 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 30. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Muscarinic Acetylcholine Receptor M4 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Muscarinic Acetylcholine Receptor M4 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Muscarinic Acetylcholine Receptor M4 Sales Value (2021-2032) & (US$ Million) Figure 34. North America Muscarinic Acetylcholine Receptor M4 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Muscarinic Acetylcholine Receptor M4 Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Muscarinic Acetylcholine Receptor M4 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Muscarinic Acetylcholine Receptor M4 Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Muscarinic Acetylcholine Receptor M4 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Muscarinic Acetylcholine Receptor M4 Sales Value (2021-2032) & (US$ Million) Figure 40. South America Muscarinic Acetylcholine Receptor M4 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Muscarinic Acetylcholine Receptor M4 Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Muscarinic Acetylcholine Receptor M4 Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Tropicamide
  • VU-0467154
  • ANAVEX-273
  • Others
Applications
  • Amnesia
  • Cognitive Disorders
  • Psychosis
  • Others
Companies covered
  • Sumitomo Dainippon Pharma Co Ltd
  • AstraZeneca Plc
  • NeuroHealing Pharmaceuticals Inc
  • Karuna Pharmaceuticals Inc
  • Heptares Therapeutics Ltd
  • Anavex Life Sciences Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Muscarinic Acetylcholine Receptor M4 Sales Value (2021-2032)
  4. 1.2.2 Global Muscarinic Acetylcholine Receptor M4 Sales Volume (2021-2032)
  5. 1.2.3 Global Muscarinic Acetylcholine Receptor M4 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Muscarinic Acetylcholine Receptor M4 Market Dynamics
  1. 2.1 Muscarinic Acetylcholine Receptor M4 Industry Trends
  2. 2.2 Muscarinic Acetylcholine Receptor M4 Industry Drivers
  3. 2.3 Muscarinic Acetylcholine Receptor M4 Industry Opportunities and Challenges
  4. 2.4 Muscarinic Acetylcholine Receptor M4 Industry Restraints
3 Muscarinic Acetylcholine Receptor M4 Market by Company
  1. 3.1 Global Muscarinic Acetylcholine Receptor M4 Company Revenue Ranking in 2025
  2. 3.2 Global Muscarinic Acetylcholine Receptor M4 Revenue by Company (2021-2026)
  3. 3.3 Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Company (2021-2026)
  4. 3.4 Global Muscarinic Acetylcholine Receptor M4 Average Price by Company (2021-2026)
  5. 3.5 Global Muscarinic Acetylcholine Receptor M4 Company Ranking (2024-2026)
  6. 3.6 Global Muscarinic Acetylcholine Receptor M4 Company Manufacturing Base and Headquarters
  7. 3.7 Global Muscarinic Acetylcholine Receptor M4 Company Product Type and Application
  8. 3.8 Global Muscarinic Acetylcholine Receptor M4 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Muscarinic Acetylcholine Receptor M4 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Muscarinic Acetylcholine Receptor M4 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Muscarinic Acetylcholine Receptor M4 Market by Type
  1. 4.1 Muscarinic Acetylcholine Receptor M4 Type Introduction
  2. 4.1.1 Tropicamide
  3. 4.1.2 VU-0467154
  4. 4.1.3 ANAVEX-273
  5. 4.1.4 Others
  6. 4.2 Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Type
  7. 4.2.1 Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Muscarinic Acetylcholine Receptor M4 Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Type
  11. 4.3.1 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Type (2021-2032)
  13. 4.3.3 Global Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type (2021-2032)
5 Muscarinic Acetylcholine Receptor M4 Market by Application
  1. 5.1 Muscarinic Acetylcholine Receptor M4 Application Introduction
  2. 5.1.1 Amnesia
  3. 5.1.2 Cognitive Disorders
  4. 5.1.3 Psychosis
  5. 5.1.4 Others
  6. 5.2 Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Application
  7. 5.2.1 Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Muscarinic Acetylcholine Receptor M4 Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Muscarinic Acetylcholine Receptor M4 Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Application
  11. 5.3.1 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Application (2021-2032)
  13. 5.3.3 Global Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application (2021-2032)
6 Muscarinic Acetylcholine Receptor M4 Regional Sales and Value Analysis
  1. 6.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Muscarinic Acetylcholine Receptor M4 Sales by Region (2021-2032)
  3. 6.2.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Region: 2021-2026
  4. 6.2.2 Global Muscarinic Acetylcholine Receptor M4 Sales by Region (2027-2032)
  5. 6.3 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Region (2027-2032)
  9. 6.5 Global Muscarinic Acetylcholine Receptor M4 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Muscarinic Acetylcholine Receptor M4 Sales Value (2021-2032)
  12. 6.6.2 North America Muscarinic Acetylcholine Receptor M4 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Muscarinic Acetylcholine Receptor M4 Sales Value (2021-2032)
  15. 6.7.2 Europe Muscarinic Acetylcholine Receptor M4 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Muscarinic Acetylcholine Receptor M4 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Muscarinic Acetylcholine Receptor M4 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Muscarinic Acetylcholine Receptor M4 Sales Value (2021-2032)
  21. 6.9.2 South America Muscarinic Acetylcholine Receptor M4 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales Value Share by Country, 2025 VS 2032
7 Muscarinic Acetylcholine Receptor M4 Country-level Sales and Value Analysis
  1. 7.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Muscarinic Acetylcholine Receptor M4 Sales by Country (2021-2032)
  4. 7.3.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Country (2021-2026)
  5. 7.3.2 Global Muscarinic Acetylcholine Receptor M4 Sales by Country (2027-2032)
  6. 7.4 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Muscarinic Acetylcholine Receptor M4 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Muscarinic Acetylcholine Receptor M4 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Muscarinic Acetylcholine Receptor M4 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Muscarinic Acetylcholine Receptor M4 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sumitomo Dainippon Pharma Co Ltd
  2. 8.1.1 Sumitomo Dainippon Pharma Co Ltd Company Information
  3. 8.1.2 Sumitomo Dainippon Pharma Co Ltd Business Overview
  4. 8.1.3 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Product Portfolio
  6. 8.1.5 Sumitomo Dainippon Pharma Co Ltd Recent Developments
  7. 8.2 AstraZeneca Plc
  8. 8.2.1 AstraZeneca Plc Company Information
  9. 8.2.2 AstraZeneca Plc Business Overview
  10. 8.2.3 AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Product Portfolio
  12. 8.2.5 AstraZeneca Plc Recent Developments
  13. 8.3 NeuroHealing Pharmaceuticals Inc
  14. 8.3.1 NeuroHealing Pharmaceuticals Inc Company Information
  15. 8.3.2 NeuroHealing Pharmaceuticals Inc Business Overview
  16. 8.3.3 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Portfolio
  18. 8.3.5 NeuroHealing Pharmaceuticals Inc Recent Developments
  19. 8.4 Karuna Pharmaceuticals Inc
  20. 8.4.1 Karuna Pharmaceuticals Inc Company Information
  21. 8.4.2 Karuna Pharmaceuticals Inc Business Overview
  22. 8.4.3 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Portfolio
  24. 8.4.5 Karuna Pharmaceuticals Inc Recent Developments
  25. 8.5 Heptares Therapeutics Ltd
  26. 8.5.1 Heptares Therapeutics Ltd Company Information
  27. 8.5.2 Heptares Therapeutics Ltd Business Overview
  28. 8.5.3 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Product Portfolio
  30. 8.5.5 Heptares Therapeutics Ltd Recent Developments
  31. 8.6 Anavex Life Sciences Corp
  32. 8.6.1 Anavex Life Sciences Corp Company Information
  33. 8.6.2 Anavex Life Sciences Corp Business Overview
  34. 8.6.3 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Product Portfolio
  36. 8.6.5 Anavex Life Sciences Corp Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Muscarinic Acetylcholine Receptor M4 Value Chain Analysis
  2. 9.1.1 Muscarinic Acetylcholine Receptor M4 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Muscarinic Acetylcholine Receptor M4 Sales Mode & Process
  6. 9.2 Muscarinic Acetylcholine Receptor M4 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Muscarinic Acetylcholine Receptor M4 Distributors
  9. 9.2.3 Muscarinic Acetylcholine Receptor M4 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst